Information for pharmacists about OST

Community pharmacies must be approved by the Department of Health to dispense opioid substitution treatment (OST). OST includes oral formulations (methadone syrup/solution and buprenorphine as Subutex or Suboxone) and injectables (depot buprenorphine) for the treatment of opioid dependency.

Approval requirements
New patients
Initial steps
Dosing
Recording

More information

Medicines and Poisons Regulation Branch
Mailing address: PO Box 8172, Perth Business Centre, WA 6849
Phone: 9222 6883
Email: MPRB@health.wa.gov.au

Last reviewed: 09-12-2024
Produced by

Medicines and Poisons Regulation Branch